Interaction between narcotics anonymous and medications for opiate use disorder among 4382 United States survey respondents
Identification
- Clé publique
- radar:r-b76f0b5592422b9c658b8ef4ee8bc1a9
- Auteurs
- Marc S. Galanter · Brooke D. Hunter · William L. White
- Année déclarée
- 2026
- Langue déclarée
- en
- Type source
- article
- Première détection
- 2026-11-14T02:38:29.456782+00:00
- Dernière observation des métadonnées
- 2026-11-14T02:38:29.456782+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
Chestnut Health Systems · New York University
Pays d’affiliation déclarés
US
Résumé documentaire — langue originale
INTRODUCTION: Individuals with opioid use disorders have historically been undertreated for their disease. These individuals may benefit from integrated treatment approaches that combine psychosocial counseling, medication for opioid use disorders (MOUD), and participation in mutual aid support groups. However, there are many barriers to integration of these recovery support modalities, including stigma and bias against MOUD within the Twelve Step community. The objective of the current study is to investigate the experience of Narcotics Anonymous (NA) members whose primary drug problem was opioids, some taking MOUD, while participating in Twelve Step meetings. METHODS: Narcotics Anonymous Worldwide Services (NAWS) conducts a triennial membership survey that is available to all members, either online or at their international membership conference. A sample of U.S. based members whose primary drug of SUD was opioids was identified (N = 4382). The sample was analyzed as a whole, as well as subdivided into groups based on utilization of MOUD and medications to treat addiction. In order to aid and improve treatment, groups were compared and characterized based on responses to a 37-item survey that included demographics, substance use history, NA involvement, and psychosocial adjustment. RESULTS: Of the sample analyzed, 944 (22.4%) were on medication for addiction when they attended their first NA meeting, and 322 (7.3%) reported MOUD use at the time of the survey. Members with past opioid addiction who were currently taking MOUD had fewer years as NA members, lower rates of sponsorship (62.9% versus 93.7%), higher rates of attendance to addiction treatment (94.0% versus 83.2%), and higher rates of taking medication for mental health issues (60.4% versus 28.8%) compared to members not taking MOUD. Members who had taken medication to treat addiction, past or present, did not statistically differ from members who had not taken medication to treat addiction regarding stable housing, educational advancement, or improved familial relationships. CONCLUSION: In order to aid in improving treatment, we distinguished characteristics of community NA members who report opioid use as a primary problem, (a) who have experience with MOUD, from (b) those who do not have experience with MOUD.
Identifiants
- OPENALEX
- https://openalex.org/W7213587396
- DOI
- 10.1016/j.josat.2026.210116
- PMID
- https://pubmed.ncbi.nlm.nih.gov/42759705
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- article
- Éditeurs
- Elsevier BV
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Marc S. Galanter; Brooke D. Hunter; William L. White. Interaction between narcotics anonymous and medications for opiate use disorder among 4382 United States survey respondents. 2026. https://doi.org/10.1016/j.josat.2026.210116
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Marc S. Galanter; Brooke D. Hunter; William L. White. (2026). Interaction between narcotics anonymous and medications for opiate use disorder among 4382 United States survey respondents. https://doi.org/10.1016/j.josat.2026.210116
- Chicago
- Marc S. Galanter; Brooke D. Hunter; William L. White. Interaction between narcotics anonymous and medications for opiate use disorder among 4382 United States survey respondents. 2026. https://doi.org/10.1016/j.josat.2026.210116
- ISO 690
- Marc S. Galanter; Brooke D. Hunter; William L. White. Interaction between narcotics anonymous and medications for opiate use disorder among 4382 United States survey respondents. 2026. https://doi.org/10.1016/j.josat.2026.210116
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. Interaction between narcotics anonymous and medications for opiate use disorder among 4382 United States survey respondents. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-b76f0b5592422b9c658b8ef4ee8bc1a9/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.1016/j.josat.2026.210116
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.